Neurogene Inc. (NASDAQ:NGNE) IPO

Neurogene Inc.

IPO

Went public as AQUINOX PHARMACEUTICALS, INC. Priced at US$11.00 a share on Mar 6, 2014.

Price
US$11.00 a share
Shares offered
4,200,000 shares of common stock
Offering size
US$46.2 million
Underwriters' option
Up to 630,000 more shares
Underwriters
Jefferies, Cowen and Company, Canaccord Genuity · In the order on the cover
Shares delivered
On or about Mar 12, 2014

Steps

StepWhen
Draft sent to the SEC in confidenceNov 18, 2013
Filed publiclyJan 28, 2014
Amended onceFeb 28, 2014
Shares registered with an exchangeMar 3, 2014
Declared effective by the SECMar 6, 2014
Final prospectus, with the priceMar 7, 2014

From the cover of the final prospectus (424B4) filed Mar 7, 2014